Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Eczema Matters

Browsing Articles Tagged with the Topic ofbiologics

Dupixent may soon be approved for teenagers

Dupixent may soon be approved for teenagers

Dupixent, a biologic drug for moderate to severe AD, may soon be available to patients aged 12 to 18 if the treatment co...

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

Following on the heels of Dupixent (dupilumab)—the first-ever biologic drug for atopic dermatitis (the most common typ...

Q & A: Introducing Biologics with Dr. Paul Yamauchi

Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis....

First Biologic Approved for Moderate to Severe Atopic Dermatitis

First Biologic Approved for Moderate to Severe Atopic Dermatitis

The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moder...

Understanding Biologic Drugs

Understanding Biologic Drugs

Biologic medications are already being used to treat diseases including rheumatoid arthritis, psoriasis and Crohn’s di...

Top Advances in Eczema Research in 2016

Top Advances in Eczema Research in 2016

There are different kinds of research when it comes to eczema. There is scientific research that tries to understand the...

Eczema Awareness Month Kicks-Off with Groundbreaking News

Eczema Awareness Month Kicks-Off with Groundbreaking News

The first biologic treatment for adults with atopic dermatitis may come to market in spring 2017....

Another Step Closer

Another Step Closer

June 9, 2016 - On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported posi...

Understanding Biologic Drugs

Understanding Biologic Drugs

Biologics are a relatively new class of medications that target specific parts of the immune system and have revolutioni...